02nd week of 2020 patent applcation highlights part 9 |
Patent application number | Title | Published |
20200009141 | CERITINIB FORMULATION | 2020-01-09 |
20200009142 | COMPOSITIONS AND METHODS OF USING TYROSINE KINASE INHIBITORS | 2020-01-09 |
20200009143 | REPURPOSING OF CANCER DRUGS FOR TREATMENT OF MYCOBACTERIUM | 2020-01-09 |
20200009144 | Combination Therapy Comprising Varlitinib and an Anticancer Agent | 2020-01-09 |
20200009145 | MEDICINAL AGENT AND BEVERAGE/FOOD FOR PREVENTING CEREBRAL DYSFUNCTION AND IMPROVING SAME | 2020-01-09 |
20200009146 | AUTOPHAGY INDUCERS FOR TREATMENT OF CNS CONDITIONS | 2020-01-09 |
20200009147 | 5-(7H-PYRROLO[2,3-d]PYRIMIDIN-4-YL)-5-AZASPIRO[2.5]OCTANE-8-CARBOXYLIC ACID DERIVATIVES AS NOVEL JAK KINASE INHIBITORS | 2020-01-09 |
20200009148 | METHODS OF TREATING AND PREVENTING GRAFT VERSUS HOST DISEASE | 2020-01-09 |
20200009149 | Methods of Treating Autism Spectrum Disorders | 2020-01-09 |
20200009150 | COMPOSITION COMPRISING URIC ACID FOR THE TREATMENT OF BRAIN STROKE PATIENTS TREATED WITH MECHANICAL THROMBECTOMY | 2020-01-09 |
20200009151 | (ALPHA-SUBSTITUTED ARALKYLAMINO AND HETEROARYLALKYLAMINO) PYRIMIDINYL AND 1,3,5-TRIAZINYL BENZIMIDAZOLES, PHARMACEUTICAL COMPOSITIONS THEREOF, AND THEIR USE IN TREATING PROLIFERATIVE DISEASES | 2020-01-09 |
20200009152 | METHOD FOR TREATING CANCER | 2020-01-09 |
20200009153 | TREATMENT OF ALCOHOL USE DISORDER | 2020-01-09 |
20200009154 | TRANSDERMAL AND/OR TOPICAL DELIVERY SYSTEM COMPRISING CLOBAZAM | 2020-01-09 |
20200009155 | Hypotensive lipid-containing biodegradable intraocular implants and related implants | 2020-01-09 |
20200009156 | FLUTICASONE EXTENDED-RELEASE FORMULATIONS AND METHODS OF USE THEREOF | 2020-01-09 |
20200009157 | DIMETHYL SULFOXIDE (DMSO) AND HYDROCORTISONE COMPOSITIONS AND METHODS OF USE | 2020-01-09 |
20200009158 | Sulfated-Oxysterol and Oxysterol Sulfation by Hydroxysterol Sulfotransferase Promote Lipid Homeostasis and Liver Tissue Regeneration | 2020-01-09 |
20200009159 | Optimizing Mifepristone Absorption | 2020-01-09 |
20200009160 | PHARMACEUTICAL SPRAY COMPOSITION COMPRISING A VITAMIND D ANALOGUE AND A CORTICOSTEROID | 2020-01-09 |
20200009161 | VITAMIN D3, HEAT SHOCK PROTEINS, AND GLUTATHIONE FOR THE TREATMENT OF CHRONIC INFLAMMATION AND CHRONIC DISEASES | 2020-01-09 |
20200009162 | 9-Aminomethyl Minocycline Compounds And Use Thereof In Treating Community-Acquired Bacterial Pneumonia (CABP) | 2020-01-09 |
20200009163 | POLYPHOSPHATES AS INHIBITORS OF CALCIUM CRYSTALLIZATION | 2020-01-09 |
20200009164 | SELF-ASSEMBLED GELS FORMED WITH ANTI-RETROVIRAL DRUGS, PRODRUGS THEREOF, AND PHARMACEUTICAL USES THEREOF | 2020-01-09 |
20200009165 | METHODS AND COMPOSITIONS FOR TREATING AND PREVENTING RESPIRATORY RELATED DISEASES AND CONDITIONS WITH XYLITOL-HEADGROUP LIPID ANALOGS | 2020-01-09 |
20200009166 | SORAFENIB OR REGORAFENIB TROXACITABINE PHOSPHORAMIDATE PRODRUG COMBINATION THERAPY FOR LIVER CANCER | 2020-01-09 |
20200009167 | Feed Composition for Improving Intraintestinal Environment | 2020-01-09 |
20200009168 | MICROBIOME REGULATORS AND RELATED USES THEREOF | 2020-01-09 |
20200009169 | COMPOUNDS, COMPOSITIONS AND METHODS FOR PREVENTION OR TREATMENT OF LIVER, LIPID, AND GLUCOSE-RELATED CONDITIONS | 2020-01-09 |
20200009170 | SLEEP DISPLAY AGENT PROPERTY AND METHOD FOR IMPROVING SLEEP DISORDERS | 2020-01-09 |
20200009171 | METHODS FOR TREATING PULMONARY NON-TUBERCULOUS MYCOBACTERIAL INFECTIONS | 2020-01-09 |
20200009172 | COMPOSITION FOR PREVENTING OR IMPROVING INFLAMMATION INCLUDING EXTRACT OF SEED OF NEW SOYBEAN CULTIVAR SCEL-1 | 2020-01-09 |
20200009173 | TRIAZOLE-CONTAINING MACROLIDES AND OPHTHALMIC USES THEREFOR | 2020-01-09 |
20200009174 | SYNERGISTIC COMPOSITION FOR MAINTENANCE OF HEALTHY BALANCE OF MICROFLORA | 2020-01-09 |
20200009175 | NUCLEOBASE ANALOGUE DERIVATIVES AND THEIR APPLICATIONS | 2020-01-09 |
20200009176 | TREATMENT OF LEUKEMIA VIA THE ADMINISTRATION OF DOT1L INHIBITOR PINOMETOSTAT | 2020-01-09 |
20200009177 | METHODS OF INHIBITING CANCER STEM CELLS WITH HMGA1 INHIBITORS | 2020-01-09 |
20200009178 | Mecobalamin for Relieving Emergency Drug Poisoning | 2020-01-09 |
20200009179 | INTRANASAL COMPOSITION OF METHYLCOBALAMIN | 2020-01-09 |
20200009180 | METHODS OF TREATING ALZHEIMER'S DISEASE | 2020-01-09 |
20200009181 | Novel Approach for Treating Cancer | 2020-01-09 |
20200009182 | METHODS AND COMPOSITIONS FOR DISRUPTING BIOFILM UTILIZING CHITOSAN-DERIVATIVE COMPOUNDS | 2020-01-09 |
20200009183 | COMPOSITIONS AND METHODS OF USE THEREOF | 2020-01-09 |
20200009184 | COMPOSITIONS AND METHODS FOR APPLICATION OVER SKIN | 2020-01-09 |
20200009185 | METHOD FOR MAINTAINING INCREASED INTRACELLULAR p53 LEVEL, INDUCED BY PLATINUM-BASED ANTICANCER DRUG, AND APPLICATION THEREOF | 2020-01-09 |
20200009186 | ANTICOAGULATION FLUID COMPRISING CITRATE AND PHOSPHATE | 2020-01-09 |
20200009187 | ECM HYDROGEL FOR TREATING ESOPHAGEAL INFLAMMATION | 2020-01-09 |
20200009188 | METHODS FOR REGULATION OF STEM CELLS | 2020-01-09 |
20200009189 | GENERATION AND USE IN ADOPTIVE IMMUNOTHERAPY OF STEM CELL-LIKE MEMORY T CELLS | 2020-01-09 |
20200009190 | IMMUNOMODULATORY FUSION PROTEINS AND USES THEREOF | 2020-01-09 |
20200009191 | COMBINATION IMMUNE THERAPY AND CYTOKINE CONTROL THERAPY FOR CANCER TREATMENT | 2020-01-09 |
20200009192 | THERAPEUTIC APOPTOTIC CELLS FOR CANCER THERAPY | 2020-01-09 |
20200009193 | PERINATAL TISSUE DERIVED MESENCHYMAL STEM CELLS: METHOD OF PREPARATION AND USES THEREOF | 2020-01-09 |
20200009194 | SYSTEMS AND METHODS FOR HEMATOPOIETIC CELL EXPANSION UTILIZING HYDROGELS | 2020-01-09 |
20200009195 | MESENCHYMAL STEM CELLS AND THERAPEUTIC AGENT FOR LIVER DISEASE | 2020-01-09 |
20200009196 | TRANSPLANTATION MEDIUM | 2020-01-09 |
20200009197 | COMPOSITIONS AND METHODS FOR THE REPROGRAMMING OF CELLS INTO CARDIOMYOCYTES | 2020-01-09 |
20200009198 | PHARMACEUTICAL COMPOSTION CONTAINING MITOCHONDRIA | 2020-01-09 |
20200009199 | Cytotherapeutics, Cytotherapeutic Units and Methods for Treatments Using Them | 2020-01-09 |
20200009200 | USE OF PECTIN OR PECTIN-RELATED SACCHARIDES TO ENHANCE EFFICACY OF PLANT GROWTH-PROMOTING RHIZOBACTERIA (PGPR) STRAINS FOR PROMOTING GROWTH AND HEALTH IN PLANTS AND ANIMALS | 2020-01-09 |
20200009201 | ORAL COMPOSITION COMPRISING LACTIC ACID BACTERIA FOR REGULATING IMMUNE RESPONSES AND METHODS RELATED THERETO | 2020-01-09 |
20200009202 | BACTERIAL COMPOSITION AND ITS USE | 2020-01-09 |
20200009203 | METHODS AND COMPOSITIONS COMPRISING VIRAL GENE THERAPY AND AN IMMUNE CHECKPOINT INHIBITOR FOR TREATMENT AND PREVENTION OF CANCER AND INFECTIOUS DISEASES | 2020-01-09 |
20200009204 | USE OF ONCOLYTIC VIRUSES, ALONE OR IN COMBINATION WITH A CHECKPOINT INHIBITOR, FOR THE TREATMENT OF CANCER | 2020-01-09 |
20200009205 | METHOD FOR PREPARATION OF PHARMACOLOGICALLY-RELEVANT COMPOUNDS FROM BOTANICAL SOURCES | 2020-01-09 |
20200009206 | METHOD FOR PREPARATION OF PHARMACOLOGICALLY-RELEVANT COMPOUNDS FROM BOTANICAL SOURCES | 2020-01-09 |
20200009207 | METHODS TO REDUCE FAT ACCUMULATION AND OXIDATIVE DAMAGE IN LIVER USING GREEN MANGO EXTRACTS AND COMPOUNDS OBTAINED THEREFROM | 2020-01-09 |
20200009208 | COMPOSITION FOR PREVENTION AND TREATMENT OF MUSCULAR DISEASES OR FOR IMPROVEMENT OF MUSCLE FUNCTION CONTAINING 3,5-DICAFFEOYLQUINIC ACID OR CHRYSANTHEMUM EXTRACT | 2020-01-09 |
20200009209 | TOPICAL MUSCLE RELAXATION COMPOSITIONS AND METHODS | 2020-01-09 |
20200009210 | Pharmaceutical Composition Comprising Indigo Pulverata Levis Extract or Fraction Thereof as Effective Ingredient for Preventing or Treating Inflammatory Bowel Disease | 2020-01-09 |
20200009211 | CURCUMIN-CONTAINING MEDICINAL PREPARATION | 2020-01-09 |
20200009212 | CYCLODEXTRIN-NLE3-A(1-7) COMPOSITIONS AND THEIR USE | 2020-01-09 |
20200009213 | Specific Increase of Dopamine Synthesis THrough Targeting of the Guanylate Cyclase 2C Receptor in the Treatment of Parkinson's Disease | 2020-01-09 |
20200009214 | Ionic Self-Assembling Peptides | 2020-01-09 |
20200009216 | Stable Formulations of Linaclotide | 2020-01-09 |
20200009217 | Ophthalmic Compositions | 2020-01-09 |
20200009218 | ORAL PHARMACEUTICAL COMPOSITION | 2020-01-09 |
20200009219 | PHARMACEUTICAL CYCLOSPORIN COMPOSITIONS | 2020-01-09 |
20200009220 | KNEE PAIN EVALUATION AND MANAGEMENT VIA WOMAC AND KOOS SYSTEMS | 2020-01-09 |
20200009221 | METHODS FOR INHIBITING NECROSIS | 2020-01-09 |
20200009222 | THERAPEUTICALLY ACTIVE COMPLEXES | 2020-01-09 |
20200009223 | METHODS FOR PREVENTING OR TREATING CERTAIN DISORDERS BY INHIBITING BINDING OF IL-4 AND/OR IL-13 TO THEIR RESPECTIVE RECEPTORS | 2020-01-09 |
20200009224 | METHODS OF BOOSTING THYMIC REGENERATION IN PATIENTS SUFFERING FROM A THYMIC INJURY BY USING RANKL | 2020-01-09 |
20200009225 | METHOD TO FUNCTIONALIZE CELLS IN HUMAN BLOOD, OTHER FLUIDS AND TISSUES USING NANOPARTICLES | 2020-01-09 |
20200009226 | Compositions and Methods for Treating Stroke | 2020-01-09 |
20200009227 | COMPOSITIONS AND METHODS OF CONTROLLING EXPRESSION OF THERMOGENIN (UCP-1) IN SKELETAL MUSCLES | 2020-01-09 |
20200009228 | THERAPEUTIC DOSING OF A NEUREGULIN OR A SUBSEQUENCE THEREOF FOR TREATMENT OR PROPHYLAXIS OF HEART FAILURE | 2020-01-09 |
20200009229 | MEANS AND METHODS FOR ORAL PROTEIN DELIVERY | 2020-01-09 |
20200009230 | COMPOSITION AND METHODS FOR TREATING ISCHEMIC WOUNDS AND INFLAMMATORY CONDITIONS | 2020-01-09 |
20200009231 | COMPOSITIONS AND METHODS FOR IMPROVED ENCAPSULATION OF FUNCTIONAL PROTEINS IN POLYMERIC VESICLES | 2020-01-09 |
20200009232 | ORODISPERSIBLE TABLET CONTAINING BURLULIPASE AND PHARMACEUTICAL COMPOSITION PRODUCED THEREFROM | 2020-01-09 |
20200009233 | AQUEOUS SOLUTION OF BURLULIPASE COMPRISING CALCIUMIONS | 2020-01-09 |
20200009234 | METHODS AND USES OF ALPHA 1-ANTITRYPSIN FOR EARLY INTERVENTION IN PULMONARY DISEASES | 2020-01-09 |
20200009235 | EXPRESSION OF VALLEY FEVER SEQUENCES IN PLANTS AND PLANT PRODUCED VACCINES FOR SAME | 2020-01-09 |
20200009236 | H3.3 CTL Peptides and Uses Thereof | 2020-01-09 |
20200009237 | NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST BREAST CANCER AND OTHER CANCERS | 2020-01-09 |
20200009238 | ENGINEERED INVARIANT CHAIN MOLECULE FOR IMPROVED MHC CLASS I LOADING | 2020-01-09 |
20200009239 | COMPOSITIONS, METHODS AND THERAPIES FOR ADMINISTERING ANTIGEN PEPTIDE | 2020-01-09 |
20200009240 | A FOOD SAFETY VACCINE TO CONTROL SALMONELLA ENTERICA AND REDUCE CAMPYLOBACTER IN POULTRY | 2020-01-09 |
20200009241 | WHOLE CELL VACCINES | 2020-01-09 |